Aspirin Does Not Prevent Pancreatic Cancer in a Large Asian Cohort
- Authors
- Kim, Min-Hyung; Park, Sang Min; Yun, Young Ho; Hwang, In Cheol
- Issue Date
- Apr-2019
- Publisher
- AMER ASSOC CANCER RESEARCH
- Citation
- CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, v.28, no.4, pp.826 - 828
- Journal Title
- CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Volume
- 28
- Number
- 4
- Start Page
- 826
- End Page
- 828
- URI
- https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/1683
- DOI
- 10.1158/1055-9965.EPI-18-1325
- ISSN
- 1055-9965
- Abstract
- Background: Evidence has suggested that aspirin reduces the incidence of several cancers, but these benefits may not occur with pancreatic cancer. Methods: A 12-year nationwide longitudinal cohort merged with the health checkup data was divided into "exposure ascertainment period" and "outcome ascertainment period" to avoid immortal time bias. The daily defined dose system was used to indicate the drug exposure. Results: We found no significant association between aspirin use and incident pancreatic cancer based on HR. Conclusions: Aspirin does not prevent pancreatic cancer. Impact: A large Asian cohort study with reliable medication information affirms no impact of aspirin on pancreatic cancer development.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 의과대학 > 의학과 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/1683)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.